A comparison of biologics in first-line advanced colorectal cancer: A Bayesian network meta-analysis of EGFR inhibitors and bevacizumab.
Alexander Kumachev
No relevant relationships to disclose
Marie Yan
No relevant relationships to disclose
Scott R. Berry
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Roche; Sanofi
Honoraria - Amgen; Bristol-Myers Squibb; Roche; Sanofi
Yoo-Joung Ko
Honoraria - Bristol-Myers Squibb; Roche
Maria Carmen Riesco Martinez
No relevant relationships to disclose
Keya Shah
No relevant relationships to disclose
Kelvin K. Chan
No relevant relationships to disclose